Evaluation of Medical and Nursing Management for Bronchiectasis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03550417|
Recruitment Status : Active, not recruiting
First Posted : June 8, 2018
Last Update Posted : March 26, 2019
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Evaluation of Medical and Nursing Management for Bronchiectasis|
|Study Start Date :||June 2015|
|Estimated Primary Completion Date :||June 2019|
|Estimated Study Completion Date :||June 2019|
Evaluation of multidisciplinary management of bronchiectasis compared to the British Thoracic Society Guidelines 2010.
Evaluation of multidisciplinary management of bronchiectasis compared to the British Thoracic Society Guidelines 2010. Comparison of 2011, 2013 cohorts & July16/June17.
Evaluation of multidisciplinary management of bronchiectasis compared to the British Thoracic Society Guidelines 2010 & 2014. Comparison of 2011, 2013 cohorts & July16/June17.
- Percentage of patients with bronchiectasis guideline compliant care [ Time Frame: 12 months ]Percentage of patients who meet guideline compliant care for management of bronchiectasis based in TSANZ and BTS guideline recommendations for outpatient management
- Number of admissions [ Time Frame: 12 months ]Service outcome includes number of emergency department attendance and admissions
- Impact of bronchiectasis outpatient management on patient outcomes [ Time Frame: 12 months ]Frequency of exacerbation reported in patient case notes (electronic and hard copy) extracted by two respiratory nurses
- Number of outpatient (OPD) attendances [ Time Frame: 12 months ]Service outcome includes respiratory and all cause OPD attendances
- Patient mortality [ Time Frame: 0 years up to 4 to 7 years dependent on qualifying year ]Mortality of patients from qualifying admission to present day
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03550417
|Study Director:||Antony Veale, PhD||The Queen Elizabeth Hospital|